Design Therapeutics, Inc. - DSGN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 3.8% | 2,366,453 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 3.8% | 2,366,453 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 3.8% | 2,366,453 | View |
| Aug 14, 2026 | SCHEDULE 13G | Sirenia Capital Management LP | 9.5% | 5,963,936 | View |
| Aug 14, 2026 | SCHEDULE 13G | Alex Silverstein | 9.5% | 5,963,936 | View |
| Jun 09, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 5.1% | 3,197,764 | View |
| Jun 09, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 5.1% | 3,197,764 | View |
| Jun 09, 2026 | SCHEDULE 13G | Steven A. Cohen | 5.1% | 3,197,764 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 4.4% | 2,722,754 | View |
| May 15, 2026 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 4.4% | 2,722,754 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven A. Cohen | 4.4% | 2,722,754 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.